NIH study shows chronic wasting disease unlikely to move from animals to people - EurekAlert

NIH funds Virginia Tech scientist's study of link between diet, diabetes, and heart disease - EurekAlert

Purdue pharmacy researcher receives $2.4 million NIH grant to fight antimicrobial-resistant lung infections - EurekAlert

Major budget cuts to two high-profile NIH efforts leave researchers reeling

Experimental NIH malaria monoclonal antibody protective in Malian children - EurekAlert

Experimental NIH Antibody Protects Children From Malaria in Clinical Trial

NIH boosts pay for postdocs and graduate students

Walk Your Way to a Longer Life: NIH Study Reveals Simple Tricks

NIH awards $3.4 million to Wayne State University to investigate biomarkers for better reproductive success - EurekAlert

NIH awards $1.9 million grant to University of Oklahoma for gene therapy research - EurekAlert

Living near green space associated with fewer emotional problems in preschool-age kids, NIH study finds - EurekAlert

Final NIH budget for 2024 is essentially flat

“Havana Syndrome” Mystery Deepens As NIH Finds No Evidence of Brain Injury

NIH probe of ‘Havana syndrome’ finds no sign of brain injuries

Federation of American Scientists recommends that the NIH create an Office of Infection-Associated Chronic Illness Research

275 million new genetic variants identified in NIH precision medicine data

Quarter-million genomes analyzed in NIH project could be ‘hugely important’ for identifying disease risks

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

Omalizumab, a recombinant humanized IgG1 monoclonal antibody, reduces allergic reactions to multiple foods in NIH trial. This could expand the amount of different common foods that children with food allergies can safely consume without eliciting an allergic reaction.

Once reluctant, new NIH chief Monica Bertagnolli has embraced her leading role